Skip to main content
. 2020 Nov 10;70(4):298–307. doi: 10.1007/s00101-020-00877-5

Fig. 4.

Fig. 4

Percentages of patients receiving other accompanying measures (a, b) or additional boluses (c, d). C/T cafedrine/theodrenaline, E ephedrine